Cargando…

SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody-Mediated Immunity

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), humans have been exposed to distinct SARS-CoV-2 antigens, either by infection with different variants, and/or vaccination. Population immunity is thus highly heterogeneous, but the impact of such heterogeneity on th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manali, Maria, Bissett, Laura A, Amat, Julien A R, Logan, Nicola, Scott, Sam, Hughes, Ellen C, Harvey, William T, Orton, Richard, Thomson, Emma C, Gunson, Rory N, Viana, Mafalda, Willett, Brian, Murcia, Pablo R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384671/ https://www.ncbi.nlm.nih.gov/pubmed/35920058 http://dx.doi.org/10.1093/infdis/jiac332

Ejemplares similares

Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting
por: Hughes, Ellen C, et al.
Publicado: (2020)

Antibody engineering for increased potency, breadth and half-life
por: Sievers, Stuart A., et al.
Publicado: (2015)

Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract
por: Dee, Kieran, et al.
Publicado: (2022)

Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019
por: Nickbakhsh, Sema, et al.
Publicado: (2020)

Diet Breadth Mediates the Prey Specificity of Venom Potency in Snakes
por: Lyons, Keith, et al.
Publicado: (2020)

Partial germline reversions can increase VRC07 potency and breadth
por: Rudicell, RS, et al.
Publicado: (2012)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023)

Increased Breadth of Group A Streptococcus Antibody Responses in Children With Acute Rheumatic Fever Compared to Precursor Pharyngitis and Skin Infections( )
por: Whitcombe, Alana L, et al.
Publicado: (2022)

Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency
por: Frumento, Nicole, et al.
Publicado: (2022)

Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design
por: Holt, Graham T., et al.
Publicado: (2023)

Antibody Avidity Maturation Following Recovery From Infection or the Booster Vaccination Grants Breadth of SARS-CoV-2 Neutralizing Capacity
por: Nakagama, Yu, et al.
Publicado: (2022)

Dose–response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodies
por: Webb, Nicholas E., et al.
Publicado: (2015)

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
por: Muecksch, Frauke, et al.
Publicado: (2021)

An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus
por: Bęczkowski, Paweł M., et al.
Publicado: (2015)

Efficacy and Safety of a Preemptive Antiviral Therapy Strategy Based on Combined Virological and Immunological Monitoring for Active Cytomegalovirus Infection in Allogeneic Stem Cell Transplant Recipients
por: Navarro, David, et al.
Publicado: (2016)

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
por: Montefiori, David C., et al.
Publicado: (2012)

Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation
por: Crooks, Ema T., et al.
Publicado: (2018)

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
por: Muecksch, Frauke, et al.
Publicado: (2021)

Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth
por: van Dorsten, Rebecca T., et al.
Publicado: (2021)

Engineering SARS-CoV-2 cocktail antibodies into a bispecific format improves neutralizing potency and breadth
por: Ku, Zhiqiang, et al.
Publicado: (2022)

Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
por: Muecksch, Frauke, et al.
Publicado: (2022)

Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study
por: Vink, Elen, et al.
Publicado: (2022)

Reliability of Self-Sampling for Accurate Assessment of Respiratory Virus Viral and Immunologic Kinetics
por: Waghmare, Alpana, et al.
Publicado: (2020)

Association of Cytomegalovirus DNA and Immunologic Markers of Cardiovascular Disease
por: Garg, Ankita, et al.
Publicado: (2019)

The Breadth of Black
Publicado: (1871)

P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
por: Powell, RL, et al.
Publicado: (2009)

An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency
por: Shen, Chenguang, et al.
Publicado: (2019)

IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody
por: Saito, Shinji, et al.
Publicado: (2019)

Potency and breadth of human primary ZIKV immune sera shows that Zika viruses cluster antigenically as a single serotype
por: Nix, Chad D., et al.
Publicado: (2020)

Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth
por: Ku, Zhiqiang, et al.
Publicado: (2022)

Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost
por: Nair, Manoj S., et al.
Publicado: (2023)

Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency
por: Easterhoff, David, et al.
Publicado: (2020)

Clinical and Immunological Markers of Pulmonary Impairment Among People With HIV in India
por: Baidya, Anurima, et al.
Publicado: (2022)

Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort
por: Chen, Ying, et al.
Publicado: (2023)

Signaling in the phytomicrobiome: breadth and potential
por: Smith, Donald L., et al.
Publicado: (2015)

Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology
por: Dee, Kieran, et al.
Publicado: (2021)

Prolonged Codelivery of Hemagglutinin and a TLR7/8 Agonist in a Supramolecular Polymer–Nanoparticle Hydrogel Enhances Potency and Breadth of Influenza Vaccination
por: Roth, Gillie A., et al.
Publicado: (2021)

DisCVR: Rapid viral diagnosis from high-throughput sequencing data
por: Maabar, Maha, et al.
Publicado: (2019)

Genital Shedding of Resistant Human Immunodeficiency Virus-1 Among Women Diagnosed With Treatment Failure by Clinical and Immunologic Monitoring
por: Graham, Susan M., et al.
Publicado: (2016)

The use of next generation sequencing in the diagnosis and typing of respiratory infections
por: Thorburn, Fiona, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r39s86f8tu5jrevpeckmqsk2g0